Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RISPERIDONE

Ingredient

RISPERIDONE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-RISPERIDONE	0.50MG	TABLET	Resolved	2017-05-10	2017-06-01	9906
APO-RISPERIDONE	0.50MG	TABLET	Resolved	2022-07-05	2022-10-31	164083
APO-RISPERIDONE	1.0MG	TABLET	Resolved	2021-05-14	2021-06-21	139425
APO-RISPERIDONE	0.50MG	TABLET	Resolved	2023-07-13	2023-08-04	198486
APO-RISPERIDONE	0.50MG	TABLET	Resolved	2021-07-16	2021-08-31	142687
APO-RISPERIDONE	0.50MG	TABLET	Resolved	2017-03-11	2017-06-01	601
APO-RISPERIDONE	0.25MG	TABLET	Resolved	2023-07-13	2023-08-18	198480
APO-RISPERIDONE	2.0MG	TABLET	Resolved	2023-05-19	2023-08-04	192803
APO-RISPERIDONE	1.0MG	TABLET	Resolved	2021-03-05	2021-06-21	135171
APO-RISPERIDONE	2.0MG	TABLET	Resolved	2021-06-04	2021-06-21	140428

Previous
1
2
3
4
5
6
…
18
Next

Showing 31 to 40 of 173

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-RISPERIDONE	4MG	TABLET	Reversed	2025-05-28	2025-06-04	258688
TEVA-RISPERIDONE	3MG	TABLET	Reversed	2025-05-28	2025-06-04	258685
TEVA-RISPERIDONE	2MG	TABLET	Reversed	2025-05-28	2025-06-04	258679

Previous
1
…
3
4
5

Showing 41 to 43 of 43